Objective: This study examined the full spectrum of comorbid disorders in all statutory-health-insured children aged 5 to 14 years with ADHD in 2017 by using nationwide claims data in Germany. Method: Children with ADHD (n = 258,662) were compared for the presence of 864 comorbid diseases with a control group matched by gender, age, and region of residence (n = 2,327,958). Results: Among others, metabolic disorders (odds ratio [OR] = 9.18; 95% confidence interval [CI] = [8.43, 9.99]), viral pneumonia (OR = 4.95; 95% CI = [2.37, 10.33]), disorders of white blood cells (OR = 4.55; 95% CI = [3.83, 5.40]), kidney failure (OR = 3.33; 95% CI = [2.65, 4.18]), hypertension (OR = 3.26; 95% CI = [3.00, 3.55]), obesity (OR = 2.85; 95% CI = [2.80, 2.91]), type 2 diabetes (OR = 2.61; 95% CI = [2.11, 3.23]), migraine (OR = 2.49; 95% CI = [2.37, 2.61]), asthma (OR = 2.19; 95% CI = [2.16, 2.22]), atopic dermatitis (OR = 2.10; 95% CI = [2.16, 2.23]), juvenile arthritis (OR = 1.56; 95% CI = [1.39, 1.76]), glaucoma (OR = 1.51; 95% CI = [1.30, 1.75]), and type 1 diabetes (OR = 1.30; 95% CI = [1.20, 1.40]) were more likely to be diagnosed in ADHD children. Conclusion: Along with psychiatric diseases, various somatic diseases were more common in ADHD children. The results have direct implications for patient care, including fine-grained diagnostics and personalized therapy.
AkmatovM. K.SteffenA.HolstiegeJ.HeringR.SchulzM.BatzingJ. (2018). Trends and regional variations in the administrative prevalence of attention-deficit/hyperactivity disorder among children and adolescents in Germany. Scientific Reports, 8(1), Article 17029.
2.
BekdasM.TufanA. E.HakyemezI. N.TasT.AltunhanH.DemirciogluF.KismetE. (2014). Subclinical immune reactions to viral infections may correlate with child and adolescent diagnosis of attention-deficit/hyperactivity disorder: A preliminary study from Turkey. African Health Sciences, 14, 439-445.
3.
BertranM.TagleF. P.IrarrazavalM. (2018). Psychiatric manifestations of 22q11.2 deletion syndrome: A literature review. Neurologia, 33, 121-128.
4.
The Brainstorm Consortium. (2018). Analysis of shared heritability in common disorders of the brain. Science, 360, Article 1313.
5.
ChenH. J.LeeY. J.YehG. C.LinH. C. (2013). Association of attention-deficit/hyperactivity disorder with diabetes: A population-based study. Pediatric Research, 73, 492-496.
6.
ChenQ.HartmanC. A.HaavikJ.HarroJ.KlungsoyrK.HegvikT. A.. . . LarssonH. (2018). Common psychiatric and metabolic comorbidity of adult attention-deficit/hyperactivity disorder: A population-based cross-sectional study. PLoS ONE, 13, e0204516.
7.
ChenQ.Kuja-HalkolaR.SjolanderA.SerlachiusE.CorteseS.FaraoneS. V.. . . LarssonH. (2017). Shared familial risk factors between attention-deficit/hyperactivity disorder and overweight/obesity—A population-based familial coaggregation study in Sweden. Journal of Child Psychology and Psychiatry, 58, 711-718.
8.
CoghillD.SoutulloC.d’AubuissonC.PreussU.LindbackT.SilverbergM.BuitelaarJ. (2008). Impact of attention-deficit/hyperactivity disorder on the patient and family: Results from a European survey. Child and Adolescent Psychiatry and Mental Health, 2, Article 31.
9.
CorteseS.Moreira-MaiaC.St-FleurD.Morcillo-PenalverC.RohdeL.FaraoneS. (2016). Association between ADHD and obesity: A systematic review and meta-analysis. American Journal of Psychiatry, 173, 34-43.
10.
CorteseS.SunS.ZhangJ.SharmaE.ChangZ.Kuja-HalkolaR.. . . FaraoneS. V. (2018). Association between attention deficit hyperactivity disorder and asthma: A systematic review and meta-analysis and a Swedish population-based study. The Lancet Psychiatry, 5, 717-726.
11.
DeCarloD. K.SwansonM.McGwinG.VisscherK.OwsleyC. (2016). ADHD and vision problems in the national survey of children’s health. Optometry and Vision Science, 93, 459-465.
12.
El-ZeinR. A.Abdel-RahmanS. Z.HayM. J.LopezM. S.BondyM. L.MorrisD. L.LegatorM. S. (2005). Cytogenetic effects in children treated with methylphenidate. Cancer Letters, 230, 284-291.
13.
InstanesJ. T.HalmoyA.EngelandA.HaavikJ.FuruK.KlungsoyrK. (2017). Attention-deficit/hyperactivity disorder in offspring of mothers with inflammatory and immune system diseases. Biological Psychiatry, 81, 452-459.
14.
InstanesJ. T.KlungsoyrK.HalmoyA.FasmerO. B.HaavikJ. (2018). Adult ADHD and comorbid somatic disease: A systematic literature review. Journal of Attention Disorders, 22, 203-228.
15.
JensenC. M.SteinhausenH. C. (2015). Comorbid mental disorders in children and adolescents with attention-deficit/hyperactivity disorder in a large nationwide study. Attention Deficit and Hyperactivity Disorders, 7, 27-38.
16.
KimJ. H.SonK. Y.ShinD. W.KimS. H.YunJ. W.ShinJ. H.. . . YunJ. M. (2016). Network analysis of human diseases using Korean nationwide claims data. Journal of Biomedical Informatics, 61, 276-282.
17.
KutukM. O.TufanA. E.GulerG.YalinO. O.AltintasE.BagH. G.. . . OzgeA. (2018). Migraine and associated comorbidities are three times more frequent in children with ADHD and their mothers. Brain and Development, 40, 857-864.
18.
LangnerI.GarbeE.BanaschewskiT.MikolajczykR. T. (2013). Twin and sibling studies using health insurance data: The example of Attention Deficit/Hyperactivity Disorder (ADHD). PLoS ONE, 8, e62177.
19.
LaugesenB.Mohr-JensenC.BoldsenS. K.JorgensenR.SorensenE. E.GronkjaerM.. . . LauritsenM. B. (2018). Attention deficit hyperactivity disorder in childhood: Healthcare use in a Danish birth cohort during the first 12 years of life. The Journal of Pediatrics, 197, 233-240.
20.
LiX.SjostedtC.SundquistJ.ZollerB.SundquistK. (2018). Familial association of attention-deficit hyperactivity disorder with autoimmune diseases in the population of Sweden. Psychiatric Genetics, 29, 37-43.
21.
LindemannC.LangnerI.BanaschewskiT.GarbeE.MikolajczykR. T. (2017). The risk of hospitalizations with injury diagnoses in a matched cohort of children and adolescents with and without attention deficit/hyperactivity disorder in Germany: A database study. Frontiers in Pediatrics, 5, Article 220.
22.
LindemannC.LangnerI.KrautA. A.BanaschewskiT.Schad-HansjostenT.PetermannU.. . . MikolajczykR. T. (2012). Age-specific prevalence, incidence of new diagnoses, and drug treatment of attention-deficit/hyperactivity disorder in Germany. Journal of Child and Adolescent Psychopharmacology, 22, 307-314.
23.
MuskensJ. B.VeldersF. P.StaalW. G. (2017). Medical comorbidities in children and adolescents with autism spectrum disorders and attention deficit hyperactivity disorders: A systematic review. European Child & Adolescent Psychiatry, 26, 1093-1103.
24.
National Association of Statutory Health Insurance Physicians. (2011). Diagnosis certainty and site location. Deutsches Arzteblatt, 108, A271-A274.
25.
NielsenP. R.BenrosM. E.DalsgaardS. (2017). Associations between autoimmune diseases and attention-deficit/hyperactivity disorder: A nationwide study. Journal of the American Academy of Child and Adolescent Psychiatry, 56, 234-240.
26.
PliszkaS. R. (2000). Patterns of psychiatric comorbidity with attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America, 9, 525-540.
27.
RedondoB.VeraJ.MolinaR.GarciaJ.OuadiM.Munoz-HoyosA.JimenezR. (2018). Attention-deficit/hyperactivity disorder children exhibit an impaired accommodative response. Graefe’s Archive for Clinical and Experimental Ophthalmology, 256, 1023-1030.
28.
SabuncuogluS.KarademirF.BerkemM. (2005). Methylphenidate treatment for severe ADHD in a bone marrow transplant child with DiGeorge’s anomaly(*). Bulletin of Clinical Psychopharmacology, 15, 134-137.
29.
SchmittJ.StadlerE.KusterD.WustenbergE. G. (2016). Medical care and treatment of allergic rhinitis: A population-based cohort study based on routine healthcare utilization data. Allergy, 71, 850-858.
ShiowL. R.ParisK.AkanaM. C.CysterJ. G.SorensenR. U.PuckJ. M. (2009). Severe Combined Immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. Clinical Immunology, 131, 24-30.
32.
SteinhausenH. C.HeleniusD. (2013). The association between medication for attention-deficit/hyperactivity disorder and cancer. Journal of Child and Adolescent Psychopharmacology, 23, 208-213.
33.
StickleyA.KoyanagiA.TakahashiH.RuchkinV.InoueY.KamioY. (2017). Attention-deficit/hyperactivity disorder and physical multimorbidity: A population-based study. European Psychiatry, 45, 227-234.
34.
StopperH.WalitzaS.WarnkeA.GerlachM. (2008). Brief review of available evidence concerning the potential induction of genomic damage by methylphenidate. Journal of Neural Transmission, 115, 331-334.
35.
VidaurreJ.TwanowJ. D. E. (2017). Attention deficit hyperactivity disorder and associated cognitive dysfunction in pediatric epilepsy. Seminars in Pediatric Neurology, 24, 282-291.
36.
WalitzaS.KampfK.OliR. G.WarnkeA.GerlachM.StopperH. (2010). Prospective follow-up studies found no chromosomal mutagenicity of methylphenidate therapy in ADHD affected children. Toxicology Letters, 193, 4-8.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
